A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Conditions

• Pulmonary Arterial Hypertension

Interventions

• BIOLOGICAL: Sotatercept
• DRUG: Placebo
• DRUG: Background PAH Therapy

Sponsor

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA